No registrations found.
ID
NL-OMON28527
Source
NTR
Brief title
SSRI FFA
Health condition
serotonergic system
Sponsors and support
Primary sponsor
:
J.J.P Kastelein
Source(s) of monetary or material Support
:
Initiator initiated
Intervention
Outcome measures
Primary outcome
Prolactin.
Secondary outcome
Lipids.
Background summary
Atherosclerosis is associated with lower serotonergic responsivity. The hypothesis in this trial is that serotonergic responsivity and free fatty acids may be associated.
Study objective
High free fatty acids lower central serotonergic responsivity.
Study design
Start 1-6-2009
Intervention
Citalopram i.v. with increase of free fattty acids.
Public
B.M. Sondermeijer
Academic Medical Center Amsterdam
Amsterdam
The Netherlands
+31 (0)205669111
b.m.sondermeijer@amc.uva.nl
Academic Medical Center Amsterdam
Amsterdam
The Netherlands
+31 (0)205669111
b.m.sondermeijer@amc.uva.nl
Scientific
B.M. Sondermeijer
Academic Medical Center Amsterdam
Amsterdam
The Netherlands
+31 (0)205669111
b.m.sondermeijer@amc.uva.nl
Academic Medical Center Amsterdam
Amsterdam
The Netherlands
+31 (0)205669111
b.m.sondermeijer@amc.uva.nl
Inclusion criteria
Healthy males.
Exclusion criteria
Psychiatric disorder.
Design
Study type
:
Interventional
Intervention model
:
Parallel
Allocation
:
Randomized controlled trial
Masking
:
Single blinded (masking used)
Control
:
Placebo
Recruitment
NL
Recruitment status
:
Pending
Start date (anticipated)
:
Enrollment
:
10
Type
:
Anticipated
Positive opinion
Date
:
Application type
:
First submission
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| NTR-new | NL1656 |
| NTR-old | NTR1755 |
| Other | AMC : 09/068 |
| ISRCTN | ISRCTN wordt niet meer aangevraagd |
Summary results
N/A